Re: BIO International 2018

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO International 2018

in response to

BIO International 2018

BearDownAZ

posted on May 16, 2018 11:18AM

It would be great if Zenith would provide a webcast of the upcoming BIO International presentation on June 3rd. Also, would be nice to have that rumored Zenith publication out before then too. Zenith has a lot of clinical trial plans, but of course trials are expensive. A lot of lingering questions about financing and rumors of buyout. Hopefully some clarity in the next few weeks.